Superior efficacy of tumor cell vaccines grown in physiologic oxygen (Q34468716)

2 August 2017

Superior efficacy of tumor cell vaccines grown in physiologic oxygen (English)

1 reference

2 August 2017

11

Bruce R Blazar

1 reference

2 August 2017

Michael R Olin

1

1 reference

2 August 2017

Brian M Andersen

2

1 reference

2 August 2017

David M Zellmer

3

1 reference

2 August 2017

Patrick T Grogan

4

1 reference

2 August 2017

Flavia E Popescu

5

1 reference

2 August 2017

Zhengming Xiong

6

1 reference

2 August 2017

Colleen L Forster

7

1 reference

2 August 2017

Charlie Seiler

8

1 reference

2 August 2017

Karen S SantaCruz

9

1 reference

2 August 2017

Wei Chen

10

1 reference

2 August 2017

John R Ohlfest

12

1 reference

2 August 2017

language of work or name

English

0 references

publication date

21 September 2010

1 reference

2 August 2017

Clinical Cancer Research

1 reference

2 August 2017

16

1 reference

2 August 2017

4800-4808

1 reference

2 August 2017

19

1 reference

Targeting the hypoxia-inducible factor (HIF) pathway in cancer.

2 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016438

Modulation of adaptive immunity with Toll-like receptors

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016438

Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016438

Physiologic oxygen concentration enhances the stem-like properties of CD133+ human glioblastoma cells in vitro.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016438

Freeze-and-thaw-disrupted tumour cells impair the responsiveness of DC to TLR stimulation.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016438

Effective CpG immunotherapy of breast carcinoma prevents but fails to eradicate established brain metastasis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016438

Optimization of dendritic cell loading with tumor cell lysates for cancer immunotherapy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016438

In vivo vaccination with tumor cell lysate plus CpG oligodeoxynucleotides eradicates murine glioblastoma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016438

HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016438

Influence of oxygen tension on CD133 phenotype in human glioma cell cultures.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016438

Cell based cancer vaccines: regulatory and commercial development

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016438

Adaptive landscapes and emergent phenotypes: why do cancers have high glycolysis?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016438

Development of TLR9 agonists for cancer therapy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016438

Transposon-based interferon gamma gene transfer overcomes limitations of episomal plasmid for immunogene therapy of glioblastoma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016438

Hypoxia and adaptive landscapes in the evolution of carcinogenesis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016438

Therapeutic potential of Toll-like receptor 9 activation

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016438

Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016438

Hypoxia is important in the biology and aggression of human glial brain tumors.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016438

Immunotherapeutic targeting of shared melanoma-associated antigens in a murine glioma model

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016438

Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016438

Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016438

Induction of heat shock proteins 27 and 72 in retinal ganglion cells after acute pressure-induced ischaemia.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016438

T regulatory cells: hypoxia-adenosinergic suppression and re-direction of the immune response

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016438

Cancer vaccines: will we ever learn?

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016438

Clinical evaluation of dendritic cell vaccination for patients with recurrent glioma: results of a clinical phase I/II trial

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016438

The first 1000 dendritic cell vaccinees.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016438

Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody

27 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20858839

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Gammadelta T-lymphocyte cytotoxic activity against Mycobacterium bovis analyzed by flow cytometry

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20858839

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1158/1078-0432.CCR-10-1572

1 reference

2 August 2017

1 reference

2 August 2017

1 reference